Sources
Loading...
Additional media
Loading...
DeepNewz, mobile.
People-sourced. AI-powered. Unbiased News.
AltruBio lands up to $225M after shift to immune drug research https://t.co/LadW415Ddt #biotech by @gwendolynawu
Another big day for AI-driven therapeutics! Following hot on the heals of @OchreBio's $35m BI Partnership, congratulations @labgeni_us on your Series B fundraise led by M Ventures and Octopus. Incredible milestone in a tough market. Kudos @jejfield 💪https://t.co/lNuU0649hs
💸🧫🔬🤖 LabGenius cements £35M to advance AI-powered antibody discovery platform. https://t.co/7SrlWPb4rD @labgeni_us @merckgroup @OctopusVentures @LGE_Global @atomico @CapitalKindred @Lux_Capital #AI #funding #London #Medtech #news #Startups https://t.co/ffceXFCfpZ
Xaira_Thera, a new biotech company utilizing AI for drug discovery, has emerged with over $1 billion in capital. LabGenius has secured $45 million in Series B funding, totaling $75 million. LabGenius also received £35 million to advance its AI-powered antibody discovery platform. AltruBio has secured up to $225 million for immune drug research.
